Evercore ISI Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $27.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price dropped by Evercore ISI from $29.00 to $27.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Evercore ISI’s price target suggests a potential upside of 11.62% from the stock’s previous close.

Other analysts have also recently issued research reports about the company. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Stifel Nicolaus reduced their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Barrington Research reissued an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Finally, Needham & Company LLC restated a “buy” rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $33.22.

DENTSPLY SIRONA Stock Down 1.2 %

Shares of XRAY traded down $0.29 during trading on Tuesday, reaching $24.19. The company’s stock had a trading volume of 462,575 shares, compared to its average volume of 3,009,588. DENTSPLY SIRONA has a twelve month low of $23.58 and a twelve month high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The company has a market cap of $5.02 billion, a price-to-earnings ratio of -54.93, a P/E/G ratio of 1.21 and a beta of 1.00. The company has a fifty day moving average of $25.43 and a two-hundred day moving average of $27.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company’s revenue was down 4.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.51 earnings per share. On average, sell-side analysts predict that DENTSPLY SIRONA will post 1.99 EPS for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors have recently bought and sold shares of XRAY. LRI Investments LLC lifted its position in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at $32,000. Central Pacific Bank Trust Division bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth $64,000. GAMMA Investing LLC grew its holdings in shares of DENTSPLY SIRONA by 133.4% in the 3rd quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier’s stock worth $67,000 after acquiring an additional 1,422 shares during the last quarter. Finally, Mather Group LLC. acquired a new stake in shares of DENTSPLY SIRONA during the first quarter worth $72,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.